BRUSSELS - "
In people with severely weakened immune systems, who have received 3 doses for their primary vaccination, it would be reasonable for public health authorities to consider administering a 4th dose
."
This was stated by the head of the EMA vaccination strategy, Marco Cavaleri.
The latest safety data provides reassurance on the use of mRna vaccines for Covid-19 during pregnancy.
The EMA reiterates this in a note. The EMA task force particularly highlights the
growing evidence that mRna vaccines "do not cause pregnancy complications for pregnant women and their babies
. "
The detailed review carried out of several studies involving approximately 65,000 pregnancies at different stages "found no signs of an increased risk of pregnancy complications, miscarriages, premature birth or adverse effects in unborn babies after mRna vaccination" .
Studies have also shown that Covid-19 vaccines are as effective in reducing the risk of hospitalization and death in pregnant people as in non-pregnant people
, the EMA adds. The most common side effects of vaccines in pregnant people also correspond to those of the overall vaccinated population. They include pain at the injection site, fatigue, headache, redness and swelling at the injection site, muscle pain and chills.
These effects are usually mild or moderate and improve within a few days of vaccination.
As pregnancy has so far been associated with a higher risk of severe Covid-19, particularly in the second and third trimesters, women who are pregnant or could become pregnant in the near future are encouraged to get vaccinated in line with national recommendations, she adds. then the European Medicines Agency.
Examination of real-world evidence suggests that "the benefits of receiving Covid-19 mRna vaccines during pregnancy outweigh any possible risk to pregnant women and unborn children
," the EMA also said.
